AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program

AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program

Submitted by admin on August 16, 2022 - 11:59pm
Source: 
Endpoints
News Tags: 
AbbVie
CD47
SEC
clinical trials
I-Mab
Zai Lab
Headline: 
AbbVie calls off PhI trial for I-Mab’s CD47 days after Zai Lab shelves its own program
snippet: 

The CD47 field ran into another hurdle Tuesday as I-Mab quietly disclosed in an SEC filing that AbbVie is saying goodbye to a Phase I study of the biotech’s drug.

Do Not Allow Advertisers to Use My Personal information